✦ LIBER ✦

A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer

✍ Scribed by Denise A. Yardley; John Zubkus; Brooke Daniel; Roger Inhorn; Cassie M. Lane; Elizabeth R. Vazquez; Yuval Naot; Howard A. Burris III; John D. Hainsworth

Book ID: 115075877
Publisher: CIG Media Group, LP.
Year: 2010
Tongue: English
Weight: 698 KB
Volume: 10
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2010.n.048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Neoadjuvant Gemcitab

A Phase II Trial of Neoadjuvant Gemcitabine, Epirubicin, and Docetaxel as Primary Treatment of Patients With Locally Advanced or Inflammatory Breast Cancer

✍ Denise A. Yardley; Nancy W. Peacock; Natalie R. Dickson; Melissa B. White; Eliza 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 609 KB

A Phase II Neoadjuvant Trial of Sequenti

A Phase II Neoadjuvant Trial of Sequential Nanoparticle Albumin-Bound Paclitaxel Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide in Locally Advanced Breast Cancer

✍ André Robidoux; Aman U. Buzdar; Emmanuel Quinaux; Samuel Jacobs; Priya Rastogi; 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 122 KB

Safety and feasibility of biweekly neoad

Safety and feasibility of biweekly neoadjuvant gemcitabine, epirubicin, and albumin bound nab-paclitaxel (GEA) in locally advanced breast cancer – results of a phase II study

✍ D. Daniel; B. Daniel; R. Inhorn; Y. Naot; J. Zubkus; L. Simons; D. Knauer; V. Tr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Gemcitabine/Epirubicin/Paclitaxel as Neo

Gemcitabine/Epirubicin/Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

✍ John T. Hamm; John W. Wilson; Priya Rastogi; Barry C. Lembersky; George C. Tseng 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 114 KB

A Phase II Trial of Neoadjuvant nab-pacl

A Phase II Trial of Neoadjuvant nab-paclitaxel, Carboplatin, and Gemcitabine (ACaG) in Patients With Locally Advanced Carcinoma of the Bladder

✍ Grivas, Petros D.; Hussain, Maha; Hafez, Khaled; Daignault-Newton, Stephanie; Wo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 366 KB

A Phase II trial of high dose epirubicin

A Phase II trial of high dose epirubicin in patients with advanced breast carcinoma

✍ Kathy D. Miller; Nikhil Munshi; David Loesch; Lawrence H. Einhorn; George W. Sle 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 3 views

## BACKGROUND. Anthracyclines are among the most active drugs in the treatment of breast carcinoma and exhibit a steep dose-response curve in vitro. This trial was performed to determine the efficacy and toxicity of epirubicin in the treatment of patients with advanced breast carcinoma when adminis